Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ADMA Biologics Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ADMA
Nasdaq
2836
https://www.admabiologics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ADMA Biologics Inc
Moderna (MRNA) Posts Pipeline Progress, Secures Blackstone Funding
- Mar 28th, 2024 3:38 pm
Praxis (PRAX) Surges on Positive Epilepsy Study Results
- Mar 27th, 2024 2:53 pm
Merck (MRK) Gets FDA Approval for New PAH Drug Winrevair
- Mar 27th, 2024 12:39 pm
Axsome's (AXSM) Narcolepsy Drug Study Meets Primary Goal
- Mar 26th, 2024 3:24 pm
AstraZeneca's (AZN) Ultomiris Gets FDA Nod for New Indication
- Mar 26th, 2024 1:56 pm
ANI Pharmaceuticals, Inc. (ANIP) Hits Fresh High: Is There Still Room to Run?
- Mar 26th, 2024 1:15 pm
Why the Market Dipped But Adma Biologics (ADMA) Gained Today
- Mar 22nd, 2024 9:50 pm
Vertex (VRTX) Kidney Disease Drug to Enter Clinical Development
- Mar 22nd, 2024 4:09 pm
Novo Nordisk (NVO) Gets Positive CHMP Opinion for Insulin Icodec
- Mar 22nd, 2024 3:53 pm
Merck's (MRK) Keytruda-Lynparza Combo Fails 2nd Lung Cancer Study
- Mar 22nd, 2024 2:26 pm
Zacks.com featured highlights QuickLogic, Willdan, Betterware, Modine Manufacturing and ADMA Biologics
- Mar 22nd, 2024 9:18 am
Lifecore (LFCR) Down 30% on Ending Strategic Review With No Deal
- Mar 21st, 2024 4:40 pm
GSK Follows Rivals, to Cap Out-of-Pocket Inhaler Cost in US
- Mar 21st, 2024 4:29 pm
ACELYRIN (SLRN) Up on Data From Thyroid Eye Disease Study
- Mar 21st, 2024 3:12 pm
Spruce Biosciences (SPRB) Falls 86% in a Month: Here's Why
- Mar 21st, 2024 2:20 pm
5 Stocks With Recent Price Strength With More Upside Left
- Mar 21st, 2024 12:40 pm
Bristol Myers (BMY) Gets EC Nod for Abecma's Label Expansion
- Mar 21st, 2024 11:53 am
PTC Therapeutics (PTCT) Up on Positive Regulatory Updates
- Mar 20th, 2024 6:00 pm
Axsome (AXSM) Begins Dosing in Depression Study on Sunosi
- Mar 20th, 2024 4:12 pm
GSK Outperforms Industry on Strength in Key Drugs & Vaccines
- Mar 20th, 2024 3:44 pm
Scroll